Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
Kintara Therapeutics, Inc. (DMPI) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/03/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
08/21/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
08/21/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
07/02/2020 3 Johnson Laura L. (Director) has filed a Form 3 on DelMar Pharmaceuticals, Inc.
06/26/2018 3 Ferrara Napoleone (Director) has filed a Form 3 on DelMar Pharmaceuticals, Inc.
04/12/2018 3 HOFFMAN ROBERT (Director) has filed a Form 3 on DelMar Pharmaceuticals, Inc.
07/11/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
02/20/2013 3 Bell John K (Director) has filed a Form 3 on DelMar Pharmaceuticals, Inc.
02/15/2013 3 Garner William J (Director) has filed a Form 3 on DelMar Pharmaceuticals, Inc.
02/15/2013 3 Brown Dennis M (Chief Scientific Officer) has filed a Form 3 on DelMar Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy